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Corticotrophin-releasing factor (CRF) is a 41 amino acid neuropeptide that coordinates
adaptive responses to stress. CRF projections from neurons in the central nucleus of
the amygdala (CeA) to the brainstem are of particular interest for their role in motivated
behavior. To directly examine the anatomy and function of CRF neurons, we generated
a BAC transgenic Crh-Cre rat in which bacterial Cre recombinase is expressed from the
Crh promoter. Using Cre-dependent reporters, we found that Cre expressing neurons
in these rats are immunoreactive for CRF and are clustered in the lateral CeA (CeL) and
the oval nucleus of the BNST. We detected major projections from CeA CRF neurons
to parabrachial nuclei and the locus coeruleus, dorsal and ventral BNST, and more
minor projections to lateral portions of the substantia nigra, ventral tegmental area, and
lateral hypothalamus. Optogenetic stimulation of CeA CRF neurons evoked GABA-ergic
responses in 11% of non-CRF neurons in the medial CeA (CeM) and 44% of non-CRF
neurons in the CeL. Chemogenetic stimulation of CeA CRF neurons induced Fos in a
similar proportion of non-CRF CeM neurons but a smaller proportion of non-CRF CeL
neurons. The CRF1 receptor antagonist R121919 reduced this Fos induction by two-
thirds in these regions. These results indicate that CeL CRF neurons provide both local
inhibitory GABA and excitatory CRF signals to other CeA neurons, and demonstrate the
value of the Crh-Cre rat as a tool for studying circuit function and physiology of CRF
neurons.
Keywords: Cre recombinase, CRF, channelrhodopsin-2, designer receptors exclusively activated by designer
drugs, transgenic rat models, central amygdala, Fos, R121919
INTRODUCTION
Corticotrophin-releasing factor (CRF) is a central regulator of endocrine, autonomic, and
behavioral responses to stressors (Koob, 2009). Although CRF cell bodies are distributed
in several brain regions, they are particularly concentrated in the central amygdala (CeA),
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the bed nucleus of the stria terminalis (BNST), and the
paraventricular hypothalamic nucleus (PVN; Wang et al., 2011).
In the PVN CRF acts as a hormone to regulate the hypothalamic-
pituitary-adrenal (HPA) axis and trigger the endocrine stress
response (Rivier and Vale, 1983). Outside of the PVN CRF
modulates synaptic transmission within specific circuits of the
central nervous system (Gallagher et al., 2008). CRF neurons of
the CeA are of particular interest, since they contribute to stress-
related arousal, conditioned fear, and negative emotional states
associated with drug withdrawal (Koob, 2009;Walker et al., 2009;
Kravets et al., 2015).
In the rat, the CeA subpopulation that expresses CRF resides
in the lateral CeA (CeL) where another, mostly non-overlapping
subpopulation expresses enkephalin (Veinante et al., 1997; Day
et al., 1999). Approximately 60% of CeL CRF neurons are
also immunoreactive for dynorphin (Marchant et al., 2007).
Anatomical studies have shown strong projections from the CeL
as a whole to the medial CeA (CeM), the brainstem (parabrachial
nucleus, reticular formation, locus coeruleus, nucleus of the
solitary tract and dorsal vagal complex) and the BNST, with
moremodest projections to the lateral hypothalamus, lateral one-
third of the substantia nigra pars compacta and an adjacent
lateral part of the retrorubral field (Petrovich and Swanson,
1997; Zahm et al., 1999; Bourgeais et al., 2001; Dong et al.,
2001). For CeL CRF neurons in particular, tract-tracing studies
have identified CRF projections from the rat CeA to the locus
coeruleus (Van Bockstaele et al., 1998; Reyes et al., 2011),
parabrachial nuclei (Moga and Gray, 1985), the midbrain central
gray (Gray and Magnuson, 1992), the dorsal vagal complex
[including the nucleus tractus solitarius (NTS)] (Gray and
Magnuson, 1987), the pontine reticular nucleus (Fendt et al.,
1997), the mesencephalic trigeminal nucleus (Sakanaka et al.,
1986), and the BNST (Sakanaka et al., 1986). Whether CeL CRF
neurons also project locally within the CeA is not clear, and
although some CRF immunoreactive fibers have been observed
in the CeM (Veening et al., 1984), their source and functional
significance are not known. Several recent studies have helped
clarify CRF architectures and functions using Crh-Cre mouse
lines (Gafford et al., 2012, 2014; Wamsteeker Cusulin et al.,
2013; McCall et al., 2015), but thorough characterization of CRF
circuits across brain structures, and moreover across species, is
still lacking.
Here, we describe a transgenic Crh-Cre rat that permits
genetic access to CRF neurons, thereby allowing direct
investigation of their anatomy and roles in physiology and
behavior. To examine CRF cell localization and projection
targets, we crossed Crh-Cre rats with a DsRed2/GFP-reporter rat,
or infected the CeA with AAVs that express Cre-dependent
mCherry, channelrhodopsin (ChR2)-eYFP, or hM3Dq-
mCherry. We found that Cre-expressing CeA neurons are
immunoreactive for CRF and project to several brain regions
in the brainstem and diencephalon. Using the Crh-Cre rat
to investigate CeL circuitry, we provide new evidence that
CRF-expressing CeL neurons act as local interneurons to
provide both inhibitory and excitatory signals to the CeL and
CeM.
MATERIALS AND METHODS
Development of Crh-Cre Rats
All animal studies were approved by the Institutional Animal Use
and Care Committees of the Ernest Gallo Clinic and Research
Center at the University of California San Francisco, the Scripps
Research Institute and of The University of Texas at Austin, and
were performed in adherence with the NIH Guide for Care and
Use of Laboratory Animals. Studies utilized male and female
Crh-Cre rats.
We identified the BAC clone CH230-206D8 from the CHORI-
230 Rat (BN/SsNHsd/MCW) BAC library, which was derived
from an inbred female brownNorway rat (Osoegawa et al., 2004),
as containing the promoter region and exons 1 and 2 of the
rat Crh gene on chromosome 2. The BAC clone has ∼80 kb
3′ of the Crh ATG and ∼143 kb of DNA 5′ of the ATG. BAC
recombineering was performed as described (Cotta-de-Almeida
et al., 2003) with vectors and bacterial host cell lines kindly
provided by Dr. Scott Snapper (Harvard Medical School).
A ∼2.7 Kb modified/enhanced Cre metallothionein-1
polyadenaylation (CREM) fragment was PCR amplified from
the plasmid p210 pCMV-CREM (Addgene # 8395; Kaczmarczyk
and Green, 2001). This fragment contains a modified human
beta-globin intron within the Cre coding sequence to prevent
expression of Cre recombinase in prokaryotes, thereby making
it suitable for interim work in bacteria with plasmids containing
loxP sites. The fragment was sub-cloned into the conditional
replicon vector pBSB-171 and confirmed by sequencing. The
plasmid pBSB-171 allows the cloning of the fragments of
interest and contains a floxed aminoglycoside kinase (aph) gene
cassette. A c-myc tag (EQKLISEEDL) was inserted (QuikChange
II XL Site Directed Mutagenesis kit, Agilent Technologies)
immediately before the Cre “stop” codon, and confirmed
by sequencing. The completed construct is referred to as
CREM-myc pBSB-171.
We designed a forward PCR primer (P1) containing 58 bp
homologous to the rat Crh sequence immediately adjacent to the
ATG of CRF followed by 31 bp of CREM-myc pBSB-171 vector
sequence, and a backward PCR primer (P2) containing 23 bp of
CREM-pBSB-171 vector sequence followed by 64 bp homologous
to the sequence immediately adjacent to the Crh stop codon. We
then amplified a fragment containing the CREM-myc-floxed aph
cassette with rat Crh homology ends by PCR with CREM-myc
pBSB-171 and primers P1, P2. Lambda red-driven recombination
between this PCR product and the BAC clone CH230-206D8
generated recombinants in which the endogenous Crh coding
sequence was replaced with the CREM-myc-floxed aph fragment.
This recombineered CH230-206D8 BAC was transformed
with the bacterial Cre expression plasmid 706-Cre;tet (Gene
Bridges Gmbh, Heidelberg, Germany) to remove the floxed
aph cassette. The recombineered circular BAC DNA without
the aph cassette was purified (Bimboim and Doly, 1979) using
a NucleoBond BAC 100 kit (Clontech # 740579). This DNA
was sent to The University of Michigan Transgenic Animal
Model Core for pronuclear injection into Hdr:W1 ES cells and
implantation (Filipiak and Saunders, 2006). Rat-tail DNA from
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resulting progeny was purified using DNeasy (Qiagen # 69506),
screened by PCR, and confirmed by sequencing to identify a
total of three founder transgenic rats. Cre-expressing cells were
identified by crossing Crh-Cre rats with the reporter rat line W-
Tg(CAG-DsRed2/GFP) 15Jms (NBRP-Rat Number 0282), which
was obtained from the National BioResource Project-Rat in
Kyoto, Japan. The reporter rat has a DsRed coding region flanked
by LoxP sites followed by a GFP sequence, all under control of
a CAG promoter. Cre recombination leads to excision of the
DsRed coding region and expression of GFP.
Surgery and Histology
We microinjected 0.8–1.2µL/side (100 nL/min) of one of the
following: AAV-Ef1α-DIO-eYFP, AAV-Ef1α-DIO-ChR2-eYFP
(Zhang et al., 2010), AAV-hSyn-DIO-mCherry (UNC Vector
Core, Chapel Hill, NC), AAV-hSyn-DIO-hM3Dq-mCherry,
or AAV-hSyn-DIO-hM4Di-mCherry (Krashes et al., 2011).
Coordinates for the CeA were AP 2.40, ML ± 4.85, DV
−8.40 from the skull in adult rats, or AP −2.0, ML ±4.3,
DV −7.9 from the skull in adolescent rats weighing 200–220 g.
Coordinates for the BNST were AP +0.00, ML ±3.5, DV −6.8
with a 16◦ angle in adolescent rats weighing 200–220 g. After
injection, we waited 10min for virus to diffuse into the tissue
before retracting the injector needle. We used adolescent rats
in several experiments to facilitate transduction down axons for
efficient labeling of neuronal projections. After 2–4 months, rats
were deeply anesthetized with sodium pentobarbital (100mg/kg,
ip) and perfused transcardially with phosphate buffered saline
(PBS) followed by 4% paraformaldehyde in PBS. Brains were
immediately removed, placed into the same fixative overnight,
and then transferred to a 30% sucrose solution at 4◦C before
sectioning at 40µm on a cryostat.
We detected co-localization of eYFP or mCherry fluorescence
with CRF, prodynorphin, preproenkephalin, somatostatin,
protein kinase C delta (PKCδ), or Fos immunoreactivity using
immunofluorescent histochemistry. Sections were washed three
times in PBS with 0.2% Triton X-100 (PBST) for 10min at
room temperature and then incubated in blocking solution
made of PBST with 3% normal donkey serum (Jackson
ImmunoResearch, number 017-000-121) or normal goat serum
(Jackson ImmunoResearch, number 005-000-121) for 1 h.
Sections were then incubated in one or more of the following
primary antibodies: rabbit anti-cFos (1:2000, Santa Cruz
Biotechnology, sc-52), goat anti-cFos (1:2000, Santa Cruz
Biotechnology, sc-52-G), mouse anti-tyrosine hydroxylase
(TH; 1:2000, Immunostar, 22941), mouse anti-tryptophan
hydroxylase (TPH; 1:1000, Sigma Aldrich, T0678), goat anti-CRF
(1:500-1000, Santa Cruz Biotechnology, sc-1761 Lot# B0315),
guinea pig anti-prodynorphin (1:500, Neuromics, GP10110),
rabbit anti-preproenkephalin (1:100, Neuromics, RA14124), or
rabbit anti-PKCδ (1:2000, Santa Cruz Biotechnology, sc-213)
with or without mouse anti-NeuN (1:2000, Millipore, MAB377
clone A60) in blocking solution rotating at 4◦C for 18–20 h.
After three 10-min washes in PBST, sections were incubated in
species-specific secondary antibodies Alexa Fluor 488, 568, or
647 (1:700, Thermo-Fisher Scientific, A-21206, A11067, A-11055,
A-21202, A- 21208, A-11073, A-21447, A-31573) in blocking
solution for 1 h at room temperature. Finally, sections were
washed four times in PBS, then mounted in 0.2% gelatin water
onto SuperFrost Plus glass slides (Fisherbrand, 12-550-15) and
coverslipped with Fluoromount-G (Southern Biotech, 0100-01).
Slides were stored in the dark before microscopy and image
acquisition.
For somatostatin staining, sections were pretreated with 50%
ethanol twice for 10min each and washed three times in PBS and
then blocked in 10% normal donkey serum at room temperature
for 10min. The sections were then incubated with rat anti-
somatostatin antibody (Millipore, MAB354) diluted 1:100 in PBS
containing 0.05% Triton-X-100 and incubated for 20 h at 4◦C
with shaking. Sections were washed for 10min three times in PBS
and then incubated with 2% NDS for 10min. Primary antibody
staining was visualized by incubating with Alexa Fluor 488-
conjugated anti-rat secondary antibody (1:700 dilution in PBS)
for 2 h. Sections were washed four times in PBS and prepared for
imaging as described above.
Peroxidase immunohistochemistry was performed using 3,3′-
diaminobenzidine tetrahydrochloride (DAB). Sections were first
washed for 30min each in 0.1M sodium phosphate buffer, pH 7.2
(PB), followed sequentially by 50% ethanol, 50% ethanol with 3%
H2O2, and then 5% normal donkey serum (NDS) in PB. Sections
were then incubated in mouse antiserum against GFP (1:1500,
Invitrogen or 1:1000, Abcam) in PB with 2% NDS and 0.2%
Triton X-10 (PBTX; 48 h at 4◦C). The sections were then washed
with PB and incubated in PBTX containing biotinylated donkey
anti-mouse IgG (1:1000, Jackson Immunoresearch Laboratories)
for 24 h at 4◦C. Finally, sections were washed in PB, incubated
with peroxidase-conjugated avidin (ExtrAvidin, Sigma-Aldrich)
in PB (1:2500; 2 h at RT), washed again, and then incubated in
DAB (ImmPACT DAB, Vector Laboratories). Sections were then
mounted with PB containing 1% gelatin, dehydrated, cleared
in xylene and coverslipped with DEPEX mounting medium
(Electron Microscopy Sciences).
Confocal Acquisition and 3D Analysis
Three-dimensional stacks of Images were acquired with a 780
Laser Scanning Confocal microscope (Zeiss, Inc.) using either
a 20x (1µm image slice), 40x (0.6µm image slice), or 63x
(0.2µm image slice) objective. The system is equipped with a
stitching stage and Zen software to reintegrate the tiled image
stacks. Stitched z series images of the entire CeA were imported
into Imaris software (Bitplane-Andor, Inc.) for quantitation. The
eYFP (green), and the CRF-A568 fluorescent labels (red) were
first three dimensionally traced using the iso-surfacing module
to obtain a clean outline of the neuronal cell body and branches,
which was then rendered solid using a control based threshold.
The isosurfaced eYFP signal was then used to create a new
channel to determine how much red signal was present within
green iso-surfaced regions. This assay was further corroborated
using the colocalization module to confirm the extent and
location of overlapping signals. The filament tracer module was
used to identify the origin of disjointed axons and outline the
neural branches of the same neuron. An alternative analysis of
green fluorescent signals within red iso-surfaced neurons was
performed for comparison. This use of multiple methods of
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analysis allowed us to quantify the location and extent of CRF-
like immunoreactivity throughout eYFP positive cell bodies and
axons. This approach was used on 1–3 sections per rat from five
rats.
Cell Counting
Immunostained sections were imaged on a Zeiss 710 LSM
confocal microscope, Zeiss Imager M2 microscope, or a Zeiss
Axio Zoom stereomicroscope. Quantification of Fos and co-
localization of -mCherry or eYFP with neuropeptides in the CeA
were performed on alternate sections from Bregma −1.90 to
−3.00 (6–12 sections per rat) using Fiji (Schindelin et al., 2012).
Electrophysiology and Optogenetics
To measure ChR2-evoked GABA IPSCs, we expressed ChR2-
eYFP in Cre-expressing neurons and recorded light-evoked
IPSCs as in recent work (Seif et al., 2013), with the following
exceptions: rats were perfused intracardially with a glycerol-
based aCSF (in mM: 252 glycerol, 2.5 KCl, 1.25NaH2PO4,
1MgCl2, 2 CaCl2, 25 NaHCO3, 1 L-ascorbate, and 11 glucose),
and then brain slices were cut in the same solution. A CsCl
internal solution (CsCl, 135; HEPES, 10; MgATP, 4; GTP, 0.3;
MgCl2, 2; EGTA, 0.5 and QX-314, 5; pH 7.23, Naylor et al.,
2010), with DNQX in the bath to block AMPARs, was used for
measuring GABA IPSCs.
To distinguish small, evoked IPSCs from spontaneous IPSCs
(sIPSCs), we recorded∼20 traces where a ChR2-eYFP+ terminal
was stimulated once with blue light at 111ms into a 1000msec
sweep. The sIPSC frequency was typically low (0.67 ± 0.13Hz),
and thus the likelihood of observing a spontaneous IPSC exactly
at the time of ChR2 stimulation in more than a few of the
20 traces was very low. If an IPSC was observed at the time
of ChR2 stimulation in only one or two of the 20 traces in a
given cell, we did not consider this a cell responding to ChR2
stimulation. Of note, sIPSCs displayed variability in amplitude
within the same cell as reported by others (Delaney and Sah,
2001), making the relative amplitude of evoked vs. spontaneous
IPSCs a less reliable measure. For spatial mapping, we used live
visualization of the electrode tip and its exact location within
the CeA instead of biocytin filling. Had we used biocytin in
these experiments, there would have been many neurons filled
within the same slice, including neurons where patch-clamping
was attempted for several minutes but failed to achieve stable
recording.
Chemogenetics and Fos Mapping
Crh-Cre rats weremicroinjected bilaterally with AAV-hSyn-DIO-
hM3Dq-mCherry, AAV-hSyn-DIO-hM4Di-mCherry, or AAV-
hSyn-DIO-mCherry into the CeL. After 2–4 months, rats
were administered intraperitoneally 2mg/kg clozapine-N-oxide
(CNO; NIMH Chemical Synthesis and Drug Supply Program)
and perfused 120min later for Fos immunohistochemistry. To
inhibit CRF1 receptors, we administered 10mg/kg R121919
(Chen et al., 2004) subcutaneously to rats 30min before
administration of CNO.
Data Analysis
Data are shown as mean ± SEM values and were analyzed by
two-tailed t-tests or by ANOVA with post-hoc Tukey’s tests using
GraphPad Prism v6.0.
RESULTS
Neurons that Express Cre in Crh-Cre Rats
are Immunoreactive for CRF
Cre-expressing cells in Crh-Cre rats were first identified by
crossing Crh-Cre rats with W-Tg(AG-DsRed2/GFP)15Jms
reporter rats and then immunostaining brain sections from
bigenic progeny with anti-GFP antibody. There were clusters
of immunoreactive neurons in the CeL and in the dorsolateral
BNST (Figures 1A,B). We confirmed the presence of Cre
activity in mature CeL and BNST neurons by microinjecting
AAV-hSyn-DIO-mCherry into the central amygdala or the
dorsal BNST of 6 week-old rats and then examining brain
slices for the presence of mCherry fluorescence 8 weeks
later (Figures 1C,D). Surprisingly we did not detect Cre
recombination in the ventral BNST or in the paraventricular
hypothalamic nucleus, even following microinjection of
a large volume (1.2µl) of Cre-dependent AAV into the
hypothalamus.
To determine if Cre-expressing neurons also express CRF,
we microinjected colchicine (4µg in 0.8µL) into the CeA 4
weeks after injection of AAV-Ef1α-DIO-eYFP and 72 h prior
to perfusion to allow CRF to accumulate in the cell soma
(Merchenthaler, 1984). We found that 94.6 ± 1.2% eYFP+
neurons were immunoreactive for CRF, while 77.1± 2.1% of CRF
immunoreactive neurons expressed eYFP (Figure 1E; n = 3 rats,
12 amygdala sections/rat).
We also examined colocalization of ChR2-eYFP and CRF
immunoreactivity in Crh-Cre rats microinjected with AAV-
Ef1α-DIO-ChR2-eYFP and not treated with colchicine. ChR2-
eYFP was present in the cell membrane of neuronal cell
bodies and processes while CRF immunoreactivity was mainly
scattered within neural processes. Because CRF is mainly
localized in neural processes, quantification of colocalization
in cell bodies using bright-field microscopy at 40x resulted
in only a small percentage (16.5 ± 2.7%) of eYFP+ neurons
being colocalized with CRF. However, confocal analysis at
63x followed by 3D reconstruction of the neuronal cell
bodies and branches using Imaris 3D software revealed that
all eYFP+ neurons contained CRF immunoreactivity in the
cell soma or branches (Figure 1F). Out of 155 neurons
analyzed, 100 ± 0% of eYFP + neurons were positive for
CRF, while 99.4 ± 0.6% of CRF+ neurons were positive for
eYFP.
Using hSyn-DIO-mCherry to identify CRF neurons, we
examined co-expression of other neuropeptides in the CeL
(Figure 2). We found that about 54.2 ± 2.8% of CRF neurons
were immunoreactive for dynorphin while there was almost
no colocalization with enkephalin, as described previously
(Veinante et al., 1997; Day et al., 1999; Marchant et al., 2007). A
population of neurons in the CeL expresses somatostatin (SOM),
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FIGURE 1 | Crh-Cre rats express Cre recombinase activity in the CeL
and dlBNST. (A,B) Bigenic progeny of a Crh-Cre X DsRed2/GFP cross
display robust GFP labeling in the CeL and dlBNST. Scale bars, 200µm.
(C,D) Cre-dependent mCherry expression in Cre-expressing neurons of the
CeL and dlBNST. Scale bars, 100µm in panel (C); 200µm in panel (D).
(E) Cre-dependent eYFP co-localizes with CRF immunoreactivity in the
CeL. Scale bar, 200µm. (F) Rendered isosurface analysis demonstrates
co-localization of CRF immunoreactivity within CeL neurons that also
express Cre-dependent eYFP. Arrows point to an example of eYFP and
CRF in the same neuron. AC, anterior commissure; AMY, amygdala; BLA,
basolateral amygdala; CeC, capsular central amygdala; CeM, medial central
amygdala; cst, commissural stria terminalis; Hip, Hippocampus; IC, internal
capsule; LV, lateral ventricle; Str, Striatum; Th, Thalamus.
and recent studies demonstrate an active role for CeL SOM+
neurons in conditioned fear in mice (Li et al., 2013; Penzo et al.,
2015). We determined that approximately 44.2 ± 0.7% of CeL
CRF neurons co-localize with SOM+ neurons. In addition to
SOM+ neurons, there is a distinct GABA-ergic subpopulation
of CeL neurons in mice that expresses protein kinase C delta
FIGURE 2 | Coexpression of other neuropeptides in CeL CRF neurons.
(A) A large percentage of CRF neurons identified by expression of
Cre-dependent mCherry are immunoreactive for dynorphin and somatostatin,
while few express enkephalin or PKCδ. Scale bars, 100µm. Medial is to the
left. (B) Quantification of mCherry expression with neuropeptide
immunoreactivity; CRF n = 3 rats, 12 amygdala sections/rat; dynorphin n = 4
rats, 6 amygdala sections/rat; somatostatin n = 4 rats, 6 amygdala
sections/rat; enkephalin n = 4 rats, 6 amygdala sections/rat; PKCδ, n = 6 rats,
10–12 amygdala sections/rat.
(PKCδ), but not CRF, and suppresses fear conditioning (Ciocchi
et al., 2010; Haubensak et al., 2010). We similarly found that
CRF and PKCδ are present in distinct populations in the
rat amygdala with only approximately 9.2 ± 1.1% of CRF
neurons co-expressing PKCδ. Also, CRF-expressing cells were
consistently more medial than PKCδ-expressing cells in the CeL
(Figure 2A).
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Projections from CeL CRF Neurons
Outside the CeA
We examined neuronal projections from CeL CRF neurons
using mCherry or ChR2-eYFP as a histological marker
(Figures 3–6). We detected projections to several regions
identified previously in nonselective tract tracing studies
of the CeL (Petrovich and Swanson, 1997; Veinante and
Freund-Mercier, 1998; Zahm et al., 1999; Bourgeais et al.,
2001; Dong et al., 2001). The largest and densest were to
the PBN and the LC (Figure 3). Fibers were present in
both the lateral and medial PBN and in the mesencephalic
trigeminal nucleus, and extended caudally within the
medial PBN to the LC. CRF fibers there appeared to be
interdigitated and orthogonal to the dorsolateral LC dendritic
field (Figure 3D).
We also observed a substantial projection from the CeL to
the dorsolateral and especially the ventral BNST (Figures 4A–C).
Dorsolateral CRF fibers appeared to cluster around the oval
nucleus and also extend into the adjacent dorsal striatum. In
addition, a small projection was detected slightly ventrolateral
to the ventral BNST in the substantia innominata and
FIGURE 3 | CeL CRF neurons project strongly to brainstem nuclei. (A)
After injection of AAV-hSyn-DIO-mCherry into the CeL, mCherry expressing
fibers were detected in the lateral and medial parabrachial nuclei (Bregma
−9.0). Scale bar, 500µm. (B) mCherry expressing fibers were also detected in
the medial parabrachial nucleus just lateral to the locus coeruleus (Bregma
-9.6). Red, mCherry; Green, Tyrosine Hydroxylase. Scale bar, 500µm. (C,D)
High-magnification examples of mCherry fibers from the CeL and
noradrenergic LC neurons. CeL fibers appear to run orthogonally to
noradrenergic dendrites extending laterally from the LC core into the medial
parabrachial nucleus. Scale bars, 100µm in panel (C); 20µm in panel (D).
MPBN, medial parabrachial nucleus; LPBN, lateral parabrachial nucleus; LC,
locus coeruleus.
ventral pallidum (Figure 4C). Caudal to the BNST, CRF
projections were present in the most lateral portion of the
lateral hypothalamus (LH) along its entire anterior-posterior
axis traveling through the nigrostriatal bundle (Figure 4D).
FIGURE 4 | CeL CRF neurons provide inputs to other limbic brain
structures. (A,B) A dense bundle of mCherry expressing fibers from the CeL
were observed in the dorsolateral and ventral BNST. (A) Rostrally, fibers
clustered mainly in the oval nucleus of the dorsal bed nucleus and in the
subcommisural zone of the ventral bed nucleus (Bregma −0.12). (B) Caudally,
dense fibers of the stria terminalis were present in the dorsal region (Bregma
−0.6). Scale bars, 200µm. (C) Less dense projections were detected ventral
and lateral to the ventral BNST in the substantia innominata and the ventral
pallidum (Bregma −0.12). Scale bar, 200µm. (D) Fibers were detected
throughout the lateral hypothalamus (Bregma -4.20) within the nigrostriatal
bundle. Scale bar, 200µm. (E) Fibers also projected dorsomedially into the
caudal dorsal raphe nucleus and ventrolateral periaqueductal gray (Bregma
−7.7). TPH, tryptophan hydroxylase. Scale bar, 200µm. (F–I) Some fibers
projected as far as the nucleus tractus solitarius where they came in close
contact to noradrenergic processes and cell bodies in the most caudal
regions. Bregma (−12.9) – (−14.0). TH, tyrosine hydroxylase. Scale bars,
200µm in panel (F); 200µm in panel (G); 100µm in panel (H); 100µm in
panel (I). ac, anterior commissure; ic, internal capsule; Str, striatum; st, stria
terminalis; VP, ventral pallidum; SIB, substantia innominata; cp, cerebral
peduncle; pLH, posterior lateral hypothalamus; Aq, central aqueduct; vlPAG,
ventrolateral periaqueductal gray; 4V, fourth ventricle.
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Most of these appeared to be fibers of passage with small
projections extending medially into the LH. Caudal to the
hypothalamus, we observed CRF fibers coursing into the
ventrolateral periaqueductal gray, and eventually into the caudal
aspect of the serotonergic dorsal raphe nucleus (Figure 4E).
Deep in the brainstem caudal to the LC, we detected a small
projection to the nucleus tractus solitarius (NTS) throughout
much of its anterior-posterior axis (Figures 4F–I). At the most
anterior aspect, CRF fibers were localized to the lateral NTS
and overlapped with tyrosine hydroxylase positive processes
but not somata (Figure 4F). Further posterior, CRF fibers
clustered within the medial NTS as it coursed toward the
4th ventricle (Figure 4G), and fibers eventually terminated in
the caudal ventrolateral NTS around noradrenergic cell bodies
(Figures 4H,I).
CRF signaling in the dopaminergic ventral tegmental area
(VTA) has garnered much attention due to its significant role
in relapse to drug seeking (Shalev et al., 2010). However, the
source of CRF in the VTA has remained controversial (Grieder
et al., 2014; Zhao-Shea et al., 2015). CRF fibers from the CeL were
present traveling through the dorsolateral substantia nigra pars
compacta, most likely as fibers of passage on their way to the
brainstem (Figures 5A–D). However, upon closer examination
we detected minor collateral projections within the rostral VTA
(Figure 5E).
Projections from CeL CRF Neurons within
the CeA
Since the CeL sends dense projections to the CeM (Petrovich and
Swanson, 1997), we investigated whether CRF expressing CeL
neurons contribute to these projections. Surprisingly, following
microinjection of AAV-hSyn-DIO-mCherry into the CeA, we
detected very few mCherry-expressing projections from the CeL
to the adjacent CeM (Figures 1C,6A). We next used AAV-Ef1α-
DIO-ChR2-eYFP to express ChR2-eYFP in CeL CRF neurons
(Figure 6B) and to detect light-evoked inhibitory postsynaptic
currents (IPSCs) in CeA neurons that did not express ChR2-
eYFP. To compare data across animals and brain slices, we
mapped the spatial position of each recorded neuron to a
common reference frame. First, we established a scale using the
intermediate capsule between the BLA and CeA as a guide. We
defined the distance between where the intermediate capsule
meets the external capsule and the ventral border of the BLA
as equal to 100 relative units (Figure 6A). We then mapped
the position of each cell onto a common Cartesian coordinate
system with the Y axis parallel to the intermediate capsule
and the origin at the most ventral part of the ovoid cluster
of CeL CRF cell bodies (Figures 6A,E). The position of each
neuron was expressed as relative units along both axes. To
assess the accuracy of this method, we mapped the position and
size of the CRF cell body cluster in slices from 12 rats. We
found that the coordinates of points defined by the intersection
of the oval border of the CeL CRF cell body cluster with
its maximal dorsal-ventral and medial-lateral diameters were
consistent across slices (Figure 6E). The borders of the CeL
CRF cell body cluster were also consistent when expressed in
relative units using the bottom of the intermediate capsule as
the origin for the coordinate system (bottom X: 22.9 ± 2.2,
Y: 19.7 ± 1.8; top X: 27.0 ± 2.0, Y: 55.0 ± 1.8; medial edge
X: 35.5 ± 2.1, Y: 44.0 ± 1.5; lateral edge X: 13.7 ± 1.4,
Y: 41.3± 1.3).
Stimulation of ChR2 evoked IPSCs in 8 of 18 (44.4%)
non-CRF CeL neurons. In contrast only 8 of 71 (11.3%) of
CeM neurons demonstrated an IPSC, concurring with our
histological findings of sparse mCherry fluorescence and eYFP
immunoreactivity of fibers within the CeM (Figures 1C,6A).
Picrotoxin (100µM) blocked light-evoked IPSCs more than 97.7
± 0.9% (n = 4; Figure 6C), as well as blocking spontaneous
FIGURE 5 | CeL CRF projections to the substantia nigra and VTA. (A)
Representative example of CeL CRF fibers in the rostral VTA and substantia
nigra pars compacta (SNc; Bregma −5.0). Scale bar, 500µm. (B) CeL CRF
fibers were observed projecting through the SNc, but not contacting the VTA
slightly more caudally (Bregma -5.5). Scale bar, 500µm. (C) CeL CRF fibers
were present at the most caudal aspects of the VTA and SNc (Bregma −6.1).
Scale bar, 500µm. (D) CeL CRF fibers course through the most dorsolateral
region of the SNc. Scale bar, 100µm. (E) Low density collaterals were present
in the rostral VTA surrounding dopamine neurons. Scale bar, 100µm. Green,
tyrosine hydroxylase.
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FIGURE 6 | ChR2 stimulation of CRF CeL terminals evokes IPSCs in a
subset of CeA neurons. (A) Coronal section through the CeA with
superimposed reference frame to identify the location of recorded neurons
across slices. (B) Example of live CeL neurons (Scale bar, 10µm) and fibers
(Scale bar, 50µM) expressing ChR2-eYFP. (C) Examples of IPSCs evoked
after stimulation of ChR2 in CRF CeL inputs, which were blocked by
picrotoxin. (D) Picrotoxin also blocked spontaneous IPSCs. (E) Diagram
showing distribution of recorded cells relative to the cluster of CRF cell bodies
and dendrites in the CeL (dotted blue circle). Filled symbols represent neurons
with IPSC responses; open symbols are neurons without evoked IPSC
responses. One CeL neuron with an IPSC response was found outside the
cluster of CRF cell bodies and dendrites but within the confines of the CeL. (F)
Similar magnitude of evoked IPSCs in CeL and CeM neurons and at two
different LED intensities. BLA, basolateral amygdala; CeL, lateral central
amygdala; CeM, medial central amygdala; LA, lateral amygdala.
IPSCs (Figure 6D), which is consistent with previous studies
demonstrating that CeA CRF neurons are GABA-ergic (Veinante
and Freund-Mercier, 1998; Cassell et al., 1999; Day et al., 1999).
The CeM neurons exhibiting light-evoked IPSCs were scattered
rather than clustered in a subregion of the CeM (Figure 6E).
The IPSC amplitudes were not different between CeM and
CeL neurons at 2 vs. 1mW of LED illumination (Figure 6F),
indicative of a weak input-output relationship for ChR2 as
TABLE 1 | IPSC kinetics for spontaneous and evoked IPSCs in CeM
neurons.
ChR2- Spontaneous Electrically-
evoked IPSC evoked
IPSC IPSC
Rise tau (ms) 0.79±0.06 0.89± 0.06 0.97± 0.13
Decay tau (ms) 8.39±1.25 10.01± 0.98 10.79± 1.34
Half-width (ms) 9.22±0.60 9.77± 0.84 11.31± 1.16
Peak amplitude (pA) 159.6±65.0 78.3± 11.3 196.1± 39.0
Area under the curve 1787±425 885± 136 2433± 514
The kinetic values for each IPSC event in a given cell were determined and then all events
for that cell were averaged. No significant differences were observed between the three
classes of IPSCs for any measure (One-way ANOVA). Data shown are from 8 CeM cells
with ChR2-evoked currents and 10 additional cells with electrically evoked IPSCs < 200
pA (peak amplitude approximately matching those of ChR2-evoked currents, since larger
IPSCs exhibit longer half-widths), with spontaneous IPSCs determined from IPSC events
in the same traces except at the time of evoked IPSCs (at 111ms into the 1 s sweep).
described (Stuber et al., 2011). Together, these results suggest
that CRF inputs target a small subset of CeM neurons. Nearly
all CeM neurons showed spontaneous ISPCs that were greatly
inhibited by picrotoxin (Figure 6D), demonstrating that most
CeM neurons can respond to synaptically released GABA. Many
cells also exhibited electrically evoked IPSCs, with kinetics similar
to those seen for spontaneous IPSCs and ChR2-evoked IPSCs
(Table 1) and previously reported for CeA IPSCs (Delaney and
Sah, 2001; Naylor et al., 2010). Thus, our optogenetic results
indicate that CeL CRF neurons send GABA-ergic projections to
almost half of their neighboring non-CRF neurons in the CeL,
but only to a small number of neurons in the CeM.
Chemogenetic Activation of Cel CRF
Neurons Induces CRF1
Receptor-Dependent c-Fos Expression in
the CeA
Since the Fos promoter is rapidly induced in strongly activated
neurons, Fos mRNA and Fos protein are commonly used as
surrogate markers of recent neuronal activation (Kaczmarek and
Chaudhuri, 1997). To identify patterns of activation downstream
of CeL CRF neurons, we examined Fos immunoreactivity
following activation of Designer Receptors Exclusively Activated
by Designer Drugs (DREADDs) expressed in CeL CRF neurons.
Systemic administration of clozapine-N-oxide (CNO, 2mg/kg)
induced Fos expression (Figures 7A,B) in CRF CeL neurons
expressing hM3Dq-mCherry, but not in CRF neurons expressing
hM4Di-mCherry or mCherry alone [F(2, 10) = 351, p < 0.0001].
These results suggest that CeL CRF neurons are relatively inactive
at baseline. We also found substantial induction of Fos in non-
CRF neurons (Figures 7C,D) throughout the CeL [F(2,10) = 27,
p < 0.0001] and in some cells of the CeM [F(2,10) = 43,
p < 0.0001]. In the CeL, the proportion that expressed Fos
was less than the proportion that exhibited IPSCs after ChR2
stimulation, while in the CeM these proportions were similar
(compare Figure 7F and Figure 6E).
Since CeL CRF neurons are GABA-ergic, we were surprised to
find that DREADD stimulation excited a subpopulation of CeA
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FIGURE 7 | CeL CRF neurons activate non-CRF neurons in the CeL and CeM. (A) Representative overlay images of Fos immunoreactivity and mCherry
fluorescence in control, hM4Di, and hM3Dq-expressing CeL neurons. Scale bar, 100µm. Insets show high-magnification examples of mCherry expressing neurons
immunostained for Fos. (B) Percentage of mCherry+ neurons co-expressing Fos following administration of CNO. (C,D) Fos induction in non-CRF neurons of the CeL
(C) and the CeM (D) after administration of CNO. ****p < 0.001 compared with Control or hM4Di, n = 4–5 rats, 10 sections/rat, Tukey’s multiple comparisons test. (E)
Representative overlay images of Fos immunoreactivity and native mCherry fluorescence in hM3Dq-expressing cells from vehicle- or R121919-treated rats. Scale bar,
100µm. (F) Percentage of Fos+ neurons in the CeL and CeM after administration of R121919. (G) Total neuron counts per amygdala section are equivalent between
groups. (H) Percentage of hM3Dq neurons expressing Fos after administration of CNO is equivalent between groups. ***p < 0.001, *p < 0.05, n = 4–5 rats, 10–12
sections/rat, Tukey’s multiple comparisons test.
neurons. We hypothesized that CRF released onto local CRF1
receptors was responsible, since CRF1 receptors are expressed
in the CeA (Van Pett et al., 2000), and in the mouse CeL CRF1
receptor activation enhances spontaneous glutamate release
(Silberman andWinder, 2013). To test this hypothesis, we treated
rats with 10mg/kg of the selective CRF1 receptor antagonist
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R121919 (Chen et al., 2004) prior to activation of hM3Dq. This
treatment reduced Fos expression in non-CRF neurons in both
CeL and CeM [Fdrug(1,14) = 40.13, p < 0.0001] (Figures 7E,F).
Importantly, the total number of neurons (Figure 7G) and the
proportion of hM3Dq-mCherry positive CRF neurons expressing
Fos were similar between R121919 and vehicle-treated groups,
indicating that the hM3Dq-driven activity of CeL CRF neurons
was not impaired by CRF1 receptor blockade [p = 0.786, t(7) =
0.282; Figure 7H]. These results demonstrate that stimulation
of CeL CRF neurons with hM3Dq excites a subpopulation
of non-CRF neurons in the CeL and CeM in a CRF1
receptor-dependent manner, presumably through local release
of CRF.
DISCUSSION
Until recently our knowledge about the anatomy of CRF
systems has rested on traditional neuroanatomical methods
and inferences about CRF function through administration of
drugs that act at CRF receptors. To gain more direct access
to CRF neurons to study their functional neuroanatomy we
generated a novel BAC transgenic Crh-Cre rat. Using Cre-
dependent reporters we found Cre recombinase expression in
neurons of the CeL and the dorsolateral BNST. There was
strong concordance of Cre-dependent transgene expression
and CRF immunoreactivity in the CeL, indicating lack of
ectopic expression of Cre recombinase in this area. CRF CeL
projections were similar to targets of CRF CeL cells identified
in previous neuroanatomical studies. However, little is known
about their local projections within the CeA, and we found
that CRF CeL neurons projected to other non-CRF CeL
cells, and also to a smaller number of CeM neurons. These
intra-CeA CRF projections exhibited both inhibitory effects,
indicated by evoked GABA currents, and excitatory effects,
indicated by increased Fos expression, which were prevented
by blocking CRF1 receptors. These findings indicate that CRF
CeL neurons are a mixed population of interneurons and
projection neurons that encode both inhibitory and excitatory
information.
Although we found CRF neurons in the CeL and dorsal
BNST, CRF cells were absent from the ventral BNST, PVN, and
other brainstem and forebrain regions where CRF neurons have
been reported (Merchenthaler, 1984; Wang et al., 2011). Thus,
despite the size of our BAC vector (∼224 kb), Cre expression
was limited to two major CRF cell populations, possibly due to
incomplete capture of all regulatory elements in the integrated
BAC transgene. Although we do not know the precise reason
for restricted CRF expression in our animals, it is notable that
CRF neurons of the dorsolateral BNST and the CeL share several
common features, including medium spiny neuron morphology
(Cassell and Gray, 1989; Phelix and Paull, 1990; Sun and
Cassell, 1993), expression of the phosphatase STEP (Dabrowska
et al., 2013b), and production of GABA (Cassell et al., 1999;
Day et al., 1999; Dabrowska et al., 2013b). In contrast, PVN
CRF neurons produce glutamate (Dabrowska et al., 2013a)
and ventral BNST CRF neurons may also be glutamatergic
(Dabrowska et al., 2013a). The Crh gene also is regulated
differently in these populations of neurons. For example, while
corticosterone suppresses CRF expression in the PVN, it up-
regulates expression in the CeA and dorsolateral BNST (Swanson
and Simmons, 1989; Makino et al., 1994). This differential
regulation could involve PKC signaling since we previously found
that production of pro-CRF mRNA and protein in the CeA,
but not in the PVN, is impaired in PKC epsilon knockout mice
(Lesscher et al., 2008). Additionally a recent study identified
novel CRF expressing neurons in the VTA, but this expression
was only detectable in animals undergoing nicotine withdrawal
(Grieder et al., 2014). The detailed mechanisms responsible for
heterogeneity in phenotypic characteristics and control of CRF
expression among subpopulations of CRF neurons remain to be
explored, but the present findings suggest our Crh-cre rats may
prove useful for selective study of one major subtype of CRF
neurons.
Using viral delivery of Cre-dependent reporters to identify
CeL CRF neurons, we found robust CRF projections from CeL
to the brainstem, terminating in the medial and lateral PBN and
the LC (Figure 8). There were also extensive projections to the
diencephalon, terminating in the dorsal and ventral BNST and
the LH. This pattern of connectivity concurs with previously
reported CeA CRF projections in the rat (Moga and Gray,
1985; Sakanaka et al., 1986; Van Bockstaele et al., 1998; Reyes
et al., 2011). We did not, however, observe projections to the
pontine reticular nuclei, as reported in earlier neuroanatomical
tracing studies (Gray and Magnuson, 1992; Fendt et al., 1997).
A previous study of neuropeptide afferents from the CeA found
CRF neurons in the CeL that contained retrograde tracer after
injections into the dorsal vagal complex (Gray and Magnuson,
1987). Our results refine this finding by demonstrating that
CeL CRF fibers specifically innervate the NTS. Since the NTS
provides noradrenergic input to the extended amygdala that
plays a role in drug withdrawal and anxiety (Smith and Aston-
Jones, 2008), it will be interesting to determine whether a
reciprocal connection between CeL CRF neurons and the NTS
exists, and whether this circuit is recruited during withdrawal
states.
FIGURE 8 | Sagittal rat brain schematic of CeL CRF neuron
projections. BNST, bed nucleus of the stria terminalis; CeL, lateral central
amygdala; DRN, dorsal raphe nuclei; LC, locus coeruleus; LH, lateral
hypothalamus; NTS, nucleus tractus solitarius; PBN, parabrachial nucleus;
SIB, Substantia innominata; SNc, substantia nigra pars compacta; vlPAG,
ventrolateral periaqueductal gray; VP, ventral pallidum.
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Within the CeA, despite extensive CeL innervation of the CeM
(Petrovich and Swanson, 1997), we surprisingly found few CeL
CRF projections to the CeM. Instead, we found that CeL CRF
neurons preferentially innervate other CeL neurons. Given the
sparseness of projections to CeM, we speculate that CeL CRF
projection neurons act in parallel with CeM projection neurons
to regulate behavior, and that the small number of direct CeL
CRF projections to the CeM, and potentially more extensive
indirect projections via non-CRF neurons in the CeL, coordinate
the actions of CeL and CeM systems on behavior. Interesting
questions for the future are whether individual CeL CRF neurons
project to many or a restricted set of targets and whether the
same or different CeL CRF neurons serve as interneurons and
projection neurons. Future studies using Crh-Cre rats and Cre-
dependent tracing tools and actuators should allow us to unravel
this circuitry in greater detail.
Despite CeL CRF neurons being GABA-ergic, activation of
the excitatory DREADD hM3Dq in these neurons induced
expression of Fos in several non-CRF neurons of the CeL and
CeM. Thus, CRF CeL neurons can generate both excitatory
(Fos) and inhibitory (GABA IPSCs) responses in CeL and CeM
neurons. Fos induction following activation of CRF CeL neurons
involved CRF release since it was substantially reduced by
administration of a CRF1 receptor antagonist. Depending on the
synapse, activation of CRF1 receptors can activate neurons by
enhancing glutamatergic transmission. For example, in the rat
lateral capsular CeA, CRF acting at CRF1 receptors enhances
glutamatergic transmission from parabrachial efferents (Ji et al.,
2013), and CRF increases the frequency of spontaneous EPSCs
in the mouse CeL through actions at CRF1 and CRF2 receptors
(Silberman and Winder, 2013). The actions of CRF on excitatory
neurotransmission in the rat CeL have yet to be determined.
Given our limited knowledge of intra-CeA circuitry, we
can envision several mechanisms by which activating CRF
CeL neurons could generate both inhibitory and excitatory
responses. First, GABA and CRF may affect different target
neurons, with GABA released at synapses and CRF released non-
synaptically to signal via local volume transmission that results in
excitation of CeA neurons through convergent disinhibition and
CRF signaling. A somewhat similar situation has been recently
described for innervation of the cerebral cortex and striatum
by histaminergic neurons of the hypothalamus that also release
GABA (Yu et al., 2015). Alternatively, excitatory effects of CRF
may be partly suppressed by concurrent GABA release, for
example where CRF acting at CRF1 receptors enhances GABA
release, as has been demonstrated in the rat CeM (Herman
et al., 2013). On the other hand, in cells having a depolarized
Cl− reversal potential, activation of GABAA receptors could
synergize with CRF to directly activate post-synaptic neurons
(Staley and Proctor, 1999), although this may bemore speculative
for adult neurons. Finally, stimulus intensity and duration may
affect GABA and CRF release differently, leading to a range of
inhibitory and excitatory responses on the same target neuron
population. Future optogenetic and chemogenetic studies using
Crh-Cre rats could help to determine if the actions of GABA and
CRF occur at the same or at different neurons and to elucidate
mechanisms by which these transmitters act.
The generation of several Crh-Cre mouse lines has facilitated
our understanding of CRF circuits and their roles in several
behavioral states. At least three Crh-Cre mouse lines have
been reported, and have been used to demonstrate roles for
CRF neurons in fear conditioning (Gafford et al., 2014),
fear extinction (Gafford et al., 2012), anxiety and avoidance
behaviors (Gafford et al., 2012; McCall et al., 2015), and
binge-like alcohol consumption (Pleil et al., 2015). However,
a recent review (Chen et al., 2015) indicates that two of
these lines, the Crh-BAC transgenic (Alon et al., 2009)
and CRFp3.0Cre (Martin et al., 2010) exhibit ectopic Cre
transgene expression, whereas Crh-IRES-Cre mice (Taniguchi
et al., 2011) express Cre with high fidelity to endogenous
CRF across the brain. Since our current rat line is a BAC
transgenic, our determination of Cre and CRF fidelity in
the amygdala (Figure 1) was critically important. Although
our rat shows limited expression of Cre, it provides a
tool to study the role of GABAergic CRF neurons of the
amygdala and dorsolateral BNST to not only complement
work done with Crh-Cre mice, but to permit investigation
of more complex behaviors such as operant conditioning and
sophisticated learning tasks that cannot easily be studied using
mice.
The anatomy of projections from CeL to CeM has been
examined recently inmousemodels of fear conditioning (Ciocchi
et al., 2010; Haubensak et al., 2010; Li et al., 2013), although
without a focus on amygdala CRF neurons or employing Crh-
Cre mice. An anatomical framework has emerged in which
fear-related cues excite BLA neurons, which in turn enhance
firing in a CeL cell subpopulation termed On-cells that inhibit
a separate CeL subpopulation termed Off-cells, the net result of
which is to disinhibit CeM neurons. The subsequent increase
in CeM activity mediates conditioned fear via projections
downstream to somatic and autonomic brainstem nuclei. In
mice the PKCδ neuron subpopulation in the CeL represents
Off-cells (Haubensak et al., 2010), which tonically suppress
CeM neurons to inhibit fear responses. On-cells in mice are
at least partially SOM+ (Li et al., 2013). In contrast, the role
of CeL CRF neurons in this fear control circuit has been
largely overlooked. Here we provide evidence consistent with rat
CRF neurons being mostly a subpopulation of On-cells based
on co-expression of SOM in about 40% of CRF neurons and
sparse projections to the CeM. Future challenges will be to
dissect the relative contribution of CRF neurons (SOM+ and
SOM-) to fear-related circuitry and behavior, and to determine
whether CRF neurons with unique neuropeptide co-expression
profiles provide distinct inputs to local and distant projection
targets.
In summary, we present a novel transgenic Cre driver rat line
that permits selective targeting of CRF-expressing GABAergic
neurons of the extended amygdala. The Crh-Cre rat will be an
important tool for dissecting extended amygdala CRF systems
in the control of fear and anxiety, as well as stress-sensitive
behaviors, such as feeding and drug seeking. Furthermore,
species-specific phenotypic differences can be evaluated by
comparing Crh-Cre rats with Crh-Cre mice, which should help
unify conclusions about CRF circuits across rodent species.
Frontiers in Neuroscience | www.frontiersin.org 11 December 2015 | Volume 9 | Article 487
Pomrenze et al. Crh-Cre BAC Transgenic Rat
AUTHOR CONTRIBUTIONS
Study concept and design: MP, EM, FH, PJ, RM. Acquisition
of data: MP, EM, FH, RK, RM, AB, VK, GD, EC. Analysis and
interpretation of data: MP, EM, FH, GD, OG, RM. Drafting of
the manuscript: EM, FH. Critical revision of the manuscript
for important intellectual content: MP, RM. Statistical analysis:
MP, FH. Obtained funding: FH, OG, PJ, RM. Administrative,
technical, and material support: EC, KR. Study supervision: FH,
PJ, RM.
FUNDING
This work was supported by pilot project funds through U01
AA013517 to FH., grants AA13588 and AA017072 to RM, and
AA020608, AA006420 and AA022977 to OG, and funds provided
by the State of California for medical research for alcohol and
substance abuse through UCSF to PJ and RM. A portion of this
work supported by the National Institute on Alcohol Abuse and
Alcoholism and the National Institute on Drug Abuse Intramural
Research Programs. MP is supported by Graduate Research
Fellowship DGE-1110007 from the National Science Foundation.
ACKNOWLEDGMENTS
The W-Tg(CAG-DsRed2/GFP) 15Jms rat line was provided by
NBRP-Rat with support in part by the National BioResource
Project ofMEXT, Japan.We acknowledgeWanda Filipiak and the
Transgenic Animal Model Core of the University of Michigan’s
Biomedical Research Core Facilities for the preparation of
transgenic rats. The current address for EM, RK, and PJ is:
Janak Lab, Department of Psychological and Brain Sciences,
Johns Hopkins University, Dunning Hall, 3400 N Charles St.,
Baltimore, MD, 21218-2686.
REFERENCES
Alon, T., Zhou, L., Pérez, C. A., Garfield, A. S., Friedman, J. M., and Heisler,
L. K. (2009). Transgenic mice expressing green fluorescent protein under the
control of the corticotropin-releasing hormone promoter. Endocrinology 150,
5626–5632. doi: 10.1210/en.2009-0881
Bimboim, H. C., and Doly, J. (1979). A rapid alkaline extraction procedure for
screening recombinant plasmid DNA. Nucleic Acids Res. 7, 1513–1523. doi:
10.1093/nar/7.6.1513
Bourgeais, L., Gauriau, C., and Bernard, J. F. (2001). Projections from the
nociceptive area of the central nucleus of the amygdala to the forebrain: a
PHA-L study in the rat. Eur. J. Neurosci. 14, 229–255. doi: 10.1046/j.0953-
816x.2001.01640.x
Cassell, M. D., Freedman, L. J., and Shi, C. (1999). The intrinsic organization
of the central extended amygdala. Ann. N.Y. Acad. Sci. 877, 217–241. doi:
10.1111/j.1749-6632.1999.tb09270.x
Cassell, M. D., and Gray, T. S. (1989). Morphology of peptide-immunoreactive
neurons in the rat central nucleus of the amygdala. J. Comp. Neurol. 281,
320–333. doi: 10.1002/cne.902810212
Chen, C., Wilcoxen, K. M., Huang, C. Q., Xie, Y. F., McCarthy, J. R., Webb,
T. R., et al. (2004). Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-
3-yl)-7-dipropylaminopyrazolo[1,5-a]py rimidine (NBI 30775/R121919) and
structure–activity relationships of a series of potent and orally active
corticotropin-releasing factor receptor antagonists. J. Med. Chem. 47,
4787–4798. doi: 10.1021/jm040058e
Chen, Y., Molet, J., Gunn, B. G., Ressler, K., and Baram, T. Z. (2015). Diversity of
reporter expression patterns in transgenic mouse lines targeting corticotropin
releasing hormone-expressing neurons. Endocrinology 156, 4769–4780. doi:
10.1210/en.2015-1673
Ciocchi, S., Herry, C., Grenier, F.,Wolff, S. B., Letzkus, J. J., Vlachos, I., et al. (2010).
Encoding of conditioned fear in central amygdala inhibitory circuits. Nature
468, 277–282. doi: 10.1038/nature09559
Cotta-de-Almeida, V., Schonhoff, S., Shibata, T., Leiter, A., and Snapper, S.
B. (2003). A new method for rapidly generating gene-targeting vectors by
engineering BACs through homologous recombination in bacteria. Genome
Res. 13, 2190–2194. doi: 10.1101/gr.1356503
Dabrowska, J., Hazra, R., Guo, J. D., Dewitt, S., and Rainnie, D. G. (2013a).
Central CRF neurons are not created equal: phenotypic differences in CRF-
containing neurons of the rat paraventricular hypothalamus and the bed
nucleus of the stria terminalis. Front. Neurosci. 7:156. doi: 10.3389/fnins.2013.
00156
Dabrowska, J., Hazra, R., Guo, J. D., Li, C., Dewitt, S., Xu, J., et al. (2013b).
Striatal-enriched protein tyrosine phosphatase-STEPs toward understanding
chronic stress-induced activation of corticotrophin releasing factor neurons in
the rat bed nucleus of the stria terminalis. Biol. Psychiatry 74, 817–826. doi:
10.1016/j.biopsych.2013.07.032
Day, H. E., Curran, E. J., Watson, S. J. Jr., and Akil, H. (1999). Distinct
neurochemical populations in the rat central nucleus of the amygdala and
bed nucleus of the stria terminalis: evidence for their selective activation by
interleukin-1beta. J. Comp. Neurol. 413, 113–128.
Delaney, A. J., and Sah, P. (2001). Pathway-specific targeting of GABA(A)
receptor subtypes to somatic and dendritic synapses in the central amygdala.
J. Neurophysiol. 86, 717–723.
Dong, H. W., Petrovich, G. D., and Swanson, L. W. (2001). Topography of
projections from amygdala to bed nuclei of the stria terminalis. Brain Res. Brain
Res. Rev. 38, 192–246. doi: 10.1016/S0165-0173(01)00079-0
Fendt, M., Koch, M., and Schnitzler, H. U. (1997). Corticotropin-releasing factor
in the caudal pontine reticular nucleus mediates the expression of fear-
potentiated startle in the rat. Eur. J. Neurosci. 9, 299–305. doi: 10.1111/j.1460-
9568.1997.tb01400.x
Filipiak, W. E., and Saunders, T. L. (2006). Advances in transgenic rat production.
Transgenic Res. 15, 673–686. doi: 10.1007/s11248-006-9002-x
Gafford, G., Jasnow, A. M., and Ressler, K. J. (2014). Grin1 receptor deletion
within CRF neurons enhances fear memory. PLoS ONE 9:e111009. doi:
10.1371/journal.pone.0111009
Gafford, G. M., Guo, J. D., Flandreau, E. I., Hazra, R., Rainnie, D. G.,
and Ressler, K. J. (2012). Cell-type specific deletion of GABA(A)alpha1
in corticotropin-releasing factor-containing neurons enhances anxiety and
disrupts fear extinction. Proc. Natl. Acad. Sci. U.S.A. 109, 16330–16335. doi:
10.1073/pnas.1119261109
Gallagher, J. P., Orozco-Cabal, L. F., Liu, J., and Shinnick-Gallagher, P. (2008).
Synaptic physiology of central CRH system. Eur. J. Pharmacol. 583, 215–225.
doi: 10.1016/j.ejphar.2007.11.075
Gray, T. S., and Magnuson, D. J. (1987). Neuropeptide neuronal efferents from
the bed nucleus of the stria terminalis and central amygdaloid nucleus to
the dorsal vagal complex in the rat. J. Comp. Neurol. 262, 365–374. doi:
10.1002/cne.902620304
Gray, T. S., and Magnuson, D. J. (1992). Peptide immunoreactive neurons in the
amygdala and the bed nucleus of the stria terminalis project to the midbrain
central gray in the rat. Peptides 13, 451–460. doi: 10.1016/0196-9781(92)
90074-D
Grieder, T. E., Herman, M. A., Contet, C., Tan, L. A., Vargas-Perez, H., Cohen,
A., et al. (2014). VTA CRF neurons mediate the aversive effects of nicotine
withdrawal and promote intake escalation. Nat. Neurosci. 17, 1751–1758. doi:
10.1038/nn.3872
Haubensak, W., Kunwar, P. S., Cai, H., Ciocchi, S., Wall, N. R., Ponnusamy,
R., et al. (2010). Genetic dissection of an amygdala microcircuit that gates
conditioned fear. Nature 468, 270–276. doi: 10.1038/nature09553
Frontiers in Neuroscience | www.frontiersin.org 12 December 2015 | Volume 9 | Article 487
Pomrenze et al. Crh-Cre BAC Transgenic Rat
Herman, M. A., Kallupi, M., Luu, G., Oleata, C. S., Heilig, M., Koob,
G. F., et al. (2013). Enhanced GABAergic transmission in the central
nucleus of the amygdala of genetically selected Marchigian Sardinian
rats: alcohol and CRF effects. Neuropharmacology 67, 337–348. doi:
10.1016/j.neuropharm.2012.11.026
Ji, G., Fu, Y., Adwanikar, H., and Neugebauer, V. (2013). Non-pain-related CRF1
activation in the amygdala facilitates synaptic transmission and pain responses.
Mol. Pain 9:2. doi: 10.1186/1744-8069-9-2
Kaczmarczyk, S. J., and Green, J. E. (2001). A single vector containing modified
cre recombinase and LOX recombination sequences for inducible tissue-
specific amplification of gene expression. Nucleic Acids Res. 29, e56. doi:
10.1093/nar/29.12.e56
Kaczmarek, L., and Chaudhuri, A. (1997). Sensory regulation of immediate-
early gene expression in mammalian visual cortex: implications for functional
mapping and neural plasticity. Brain Res. Brain Res. Rev. 23, 237–256. doi:
10.1016/S0165-0173(97)00005-2
Koob, G. F. (2009). Brain stress systems in the amygdala and addiction. Brain Res.
1293, 61–75. doi: 10.1016/j.brainres.2009.03.038
Krashes, M. J., Koda, S., Ye, C., Rogan, S. C., Adams, A. C., Cusher, D. S., et al.
(2011). Rapid, reversible activation of AgRP neurons drives feeding behavior in
mice. J. Clin. Invest. 121, 1424–1428. doi: 10.1172/JCI46229
Kravets, J. L., Reyes, B. A., Unterwald, E. M., and Van Bockstaele, E. J. (2015).
Direct targeting of peptidergic amygdalar neurons by noradrenergic afferents:
linking stress-integrative circuitry. Brain Struct. Funct. 220, 541–558. doi:
10.1007/s00429-013-0674-8
Lesscher, H. M., McMahon, T., Lasek, A. W., Chou, W. H., Connolly, J., Kharazia,
V., et al. (2008). Amygdala protein kinase C epsilon regulates corticotropin-
releasing factor and anxiety-like behavior. Genes Brain Behav. 7, 323–333. doi:
10.1111/j.1601-183X.2007.00356.x
Li, H., Penzo, M. A., Taniguchi, H., Kopec, C. D., Huang, Z. J., and Li, B. (2013).
Experience-dependent modification of a central amygdala fear circuit. Nat.
Neurosci. 16, 332–339. doi: 10.1038/nn.3322
Makino, S., Gold, P. W., and Schulkin, J. (1994). Effects of corticosterone on CRH
mRNA and content in the bed nucleus of the stria terminalis; comparison
with the effects in the central nucleus of the amygdala and the paraventricular
nucleus of the hypothalamus. Brain Res. 657, 141–149. doi: 10.1016/0006-
8993(94)90961-X
Marchant, N. J., Densmore, V. S., and Osborne, P. B. (2007). Coexpression
of prodynorphin and corticotrophin-releasing hormone in the rat central
amygdala: evidence of two distinct endogenous opioid systems in the lateral
division. J. Comp. Neurol. 504, 702–715. doi: 10.1002/cne.21464
Martin, E. I., Ressler, K. J., Jasnow, A. M., Dabrowska, J., Hazra, R., Rainnie,
D. G., et al. (2010). A novel transgenic mouse for gene-targeting within cells
that express corticotropin-releasing factor. Biol. Psychiatry 67, 1212–1216. doi:
10.1016/j.biopsych.2010.01.026
McCall, J. G., Al-Hasani, R., Siuda, E. R., Hong, D. Y., Norris, A. J., Ford, C. P., et al.
(2015). CRH engagement of the locus coeruleus noradrenergic systemmediates
stress-induced anxiety. Neuron 87, 605–620. doi: 10.1016/j.neuron.2015.07.002
Merchenthaler, I. (1984). Corticotropin releasing factor (CRF)-like
immunoreactivity in the rat central nervous system. Extrahypothalamic
distribution. Peptides 5(Suppl. 1), 53–69. doi: 10.1016/0196-9781(84)90265-1
Moga, M. M., and Gray, T. S. (1985). Evidence for corticotropin-releasing factor,
neurotensin, and somatostatin in the neural pathway from the central nucleus
of the amygdala to the parabrachial nucleus. J. Comp. Neurol. 241, 275–284. doi:
10.1002/cne.902410304
Naylor, J. C., Li, Q., Kang-Park, M. H., Wilson, W. A., Kuhn, C., and Moore,
S. D. (2010). Dopamine attenuates evoked inhibitory synaptic currents in
central amygdala neurons. Eur. J. Neurosci. 32, 1836–1842. doi: 10.1111/j.1460-
9568.2010.07457.x
Osoegawa, K., Zhu, B., Shu, C. L., Ren, T., Cao, Q., Vessere, G. M., et al. (2004).
BAC resources for the rat genome project. Genome Res. 14, 780–785. doi:
10.1101/gr.2033904
Penzo, M. A., Robert, V., Tucciarone, J., De Bundel, D., Wang, M., Van Aelst, L.,
et al. (2015). The paraventricular thalamus controls a central amygdala fear
circuit. Nature 519, 455–459. doi: 10.1038/nature13978
Petrovich, G. D., and Swanson, L. W. (1997). Projections from the lateral part of
the central amygdalar nucleus to the postulated fear conditioning circuit. Brain
Res. 763, 247–254. doi: 10.1016/S0006-8993(96)01361-3
Phelix, C. F., and Paull, W. K. (1990). Demonstration of distinct corticotropin
releasing factor–containing neuron populations in the bed nucleus of the stria
terminalis. A light and electron microscopic immunocytochemical study in the
rat. Histochemistry 94, 345–364. doi: 10.1007/BF00266441
Pleil, K. E., Rinker, J. A., Lowery-Gionta, E. G., Mazzone, C. M., McCall, N. M.,
Kendra, A. M., et al. (2015). NPY signaling inhibits extended amygdala CRF
neurons to suppress binge alcohol drinking. Nat. Neurosci. 18, 545–552. doi:
10.1038/nn.3972
Reyes, B. A., Carvalho, A. F., Vakharia, K., and Van Bockstaele, E. J. (2011).
Amygdalar peptidergic circuits regulating noradrenergic locus coeruleus
neurons: linking limbic and arousal centers. Exp. Neurol. 230, 96–105. doi:
10.1016/j.expneurol.2011.04.001
Rivier, C., and Vale, W. (1983). Modulation of stress-induced ACTH release by
corticotropin-releasing factor, catecholamines and vasopressin. Nature 305,
325–327. doi: 10.1038/305325a0
Sakanaka, M., Shibasaki, T., and Lederis, K. (1986). Distribution and efferent
projections of corticotropin-releasing factor-like immunoreactivity in the
rat amygdaloid complex. Brain Res. 382, 213–238. doi: 10.1016/0006-
8993(86)91332-6
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T.,
et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat.
Methods 9, 676–682. doi: 10.1038/nmeth.2019
Seif, T., Chang, S. J., Simms, J. A., Gibb, S. L., Dadgar, J., Chen, B. T., et al.
(2013). Cortical activation of accumbens hyperpolarization-active NMDARs
mediates aversion-resistant alcohol intake. Nat. Neurosci. 16, 1094–1100. doi:
10.1038/nn.3445
Shalev, U., Erb, S., and Shaham, Y. (2010). Role of CRF and other neuropeptides
in stress-induced reinstatement of drug seeking. Brain Res. 1314, 15–28. doi:
10.1016/j.brainres.2009.07.028
Silberman, Y., and Winder, D. G. (2013). Corticotropin releasing factor
and catecholamines enhance glutamatergic neurotransmission in the lateral
subdivision of the central amygdala. Neuropharmacology 70, 316–323. doi:
10.1016/j.neuropharm.2013.02.014
Smith, R. J., and Aston-Jones, G. (2008). Noradrenergic transmission in
the extended amygdala: role in increased drug-seeking and relapse
during protracted drug abstinence. Brain Struct. Funct. 213, 43–61. doi:
10.1007/s00429-008-0191-3
Staley, K. J., and Proctor, W. R. (1999). Modulation of mammalian dendritic
GABA(A) receptor function by the kinetics of Cl- and HCO3- transport.
J. Physiol. 519(Pt 3), 693–712. doi: 10.1111/j.1469-7793.1999.0693n.x
Stuber, G. D., Sparta, D. R., Stamatakis, A.M., van Leeuwen,W. A., Hardjoprajitno,
J. E., Cho, S., et al. (2011). Excitatory transmission from the amygdala
to nucleus accumbens facilitates reward seeking. Nature 475, 377–380. doi:
10.1038/nature10194
Sun, N., and Cassell, M. D. (1993). Intrinsic GABAergic neurons in the rat central
extended amygdala. J. Comp. Neurol. 330, 381–404. doi: 10.1002/cne.903300308
Swanson, L. W., and Simmons, D. M. (1989). Differential steroid hormone and
neural influences on peptide mRNA levels in CRH cells of the paraventricular
nucleus: a hybridization histochemical study in the rat. J. Comp. Neurol. 285,
413–435. doi: 10.1002/cne.902850402
Taniguchi, H., He, M., Wu, P., Kim, S., Paik, R., Sugino, K., et al. (2011). A resource
of Cre driver lines for genetic targeting of GABAergic neurons in cerebral
cortex. Neuron 71, 995–1013. doi: 10.1016/j.neuron.2011.07.026
Van Bockstaele, E. J., Colago, E. E., and Valentino, R. J. (1998). Amygdaloid
corticotropin-releasing factor targets locus coeruleus dendrites: substrate for
the co-ordination of emotional and cognitive limbs of the stress response.
J. Neuroendocrinol. 10, 743–757. doi: 10.1046/j.1365-2826.1998.00254.x
Van Pett, K., Viau, V., Bittencourt, J. C., Chan, R. K., Li, H. Y., Arias, C.,
et al. (2000). Distribution of mRNAs encoding CRF receptors in brain and
pituitary of rat and mouse. J. Comp. Neurol. 428, 191–212. doi: 10.1002/1096-
9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U
Veening, J. G., Swanson, L. W., and Sawchenko, P. E. (1984). The organization
of projections from the central nucleus of the amygdala to brainstem sites
involved in central autonomic regulation: a combined retrograde transport-
immunohistochemical study. Brain Res. 303, 337–357. doi: 10.1016/0006-
8993(84)91220-4
Veinante, P., and Freund-Mercier, M. J. (1998). Intrinsic and extrinsic connections
of the rat central extended amygdala: an in vivo electrophysiological study of
Frontiers in Neuroscience | www.frontiersin.org 13 December 2015 | Volume 9 | Article 487
Pomrenze et al. Crh-Cre BAC Transgenic Rat
the central amygdaloid nucleus. Brain Res. 794, 188–198. doi: 10.1016/S0006-
8993(98)00228-5
Veinante, P., Stoeckel, M. E., and Freund-Mercier, M. J. (1997). GABA- and
peptide-immunoreactivities co-localize in the rat central extended amygdala.
Neuroreport 8, 2985–2989. doi: 10.1097/00001756-199709080-00035
Walker, D. L., Miles, L. A., and Davis, M. (2009). Selective participation of the
bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus
phasic fear-like responses. Prog. Neuropsychopharmacol. Biol. Psychiatry 33,
1291–1308. doi: 10.1016/j.pnpbp.2009.06.022
Wamsteeker Cusulin, J. I., Füzesi, T., Watts, A. G., and Bains, J. S.
(2013). Characterization of corticotropin-releasing hormone neurons in the
paraventricular nucleus of the hypothalamus of Crh-IRES-Cre mutant mice.
PLoS ONE 8:e64943. doi: 10.1371/journal.pone.0064943
Wang, L., Goebel-Stengel, M., Stengel, A., Wu, S. V., Ohning, G., and Taché,
Y. (2011). Comparison of CRF-immunoreactive neurons distribution in
mouse and rat brains and selective induction of Fos in rat hypothalamic
CRF neurons by abdominal surgery. Brain Res. 1415, 34–46. doi:
10.1016/j.brainres.2011.07.024
Yu, X., Ye, Z., Houston, C. M., Zecharia, A. Y., Ma, Y., Zhang, Z., et al. (2015).
Wakefulness is governed by GABA and histamine cotransmission. Neuron 87,
164–178. doi: 10.1016/j.neuron.2015.06.003
Zahm, D. S., Jensen, S. L., Williams, E. S., and Martin, J. R. III (1999).
Direct comparison of projections from the central amygdaloid region and
nucleus accumbens shell. Eur. J. Neurosci. 11, 1119–1126. doi: 10.1046/j.1460-
9568.1999.00524.x
Zhang, F., Gradinaru, V., Adamantidis, A. R., Durand, R., Airan, R. D., de
Lecea, L., et al. (2010). Optogenetic interrogation of neural circuits: technology
for probing mammalian brain structures. Nat. Protoc. 5, 439–456. doi:
10.1038/nprot.2009.226
Zhao-Shea, R., DeGroot, S. R., Liu, L., Vallaster, M., Pang, X., Su, Q.,
et al. (2015). Increased CRF signalling in a ventral tegmental area-
interpeduncular nucleus-medial habenula circuit induces anxiety during
nicotine withdrawal. Nat. Commun. 6, 6770. doi: 10.1038/ncomms
7770
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Pomrenze,Millan, Hopf, Keiflin,Maiya, Blasio, Dadgar, Kharazia,
De Guglielmo, Crawford, Janak, George, Rice and Messing. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 14 December 2015 | Volume 9 | Article 487
